Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project

請用此 Handle URI 來引用此文件： http://scholars.ntou.edu.tw/handle/123456789/1297

標題:	Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project
作者:	Kim, Y. H. Tavallaee, M. Sundram, U. Salva, K. A. Wood, G. S. Li, S. F. Rozati, S. Nagpal, S. Krathen, M. Reddy, S. Hoppe, R. T. Nguyen-Lin, A. Wen-Kai Weng Armstrong, R. Pulitzer, M. Advani, R. H. Horwitz, S. M.
公開日期:	十一月-2015
卷:	33
期:	32
來源出版物:	Journal of Clinical Oncology
URI:	http://scholars.ntou.edu.tw/handle/123456789/1297
ISSN:	0732-183X
DOI:	10.1200/jco.2014.60.3969 ://WOS:000366020100014
顯示於：	河海工程學系

顯示文件完整紀錄

上周
0

上個月
0

checked on 2022/10/13

檢查

TAIR相關文章